256 related articles for article (PubMed ID: 31889501)
41. Down-regulatory effects of green coffee extract on las I and las R virulence-associated genes in Pseudomonas aeruginosa.
Jamalifar H; Samadi N; Nowroozi J; Dezfulian M; Fazeli MR
Daru; 2019 Jun; 27(1):35-42. PubMed ID: 31187452
[TBL] [Abstract][Full Text] [Related]
42. The Prevalence of Exoenzyme S Gene in Multidrug-Sensitive and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains.
Bogiel T; Deptuła A; Kwiecińska-Piróg J; Prażyńska M; Mikucka A; Gospodarek-Komkowska E
Pol J Microbiol; 2017 Dec; 66(4):427-431. PubMed ID: 29313517
[TBL] [Abstract][Full Text] [Related]
43. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
44. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
45. Pathogenic and phylogenetic features of 2 multiresistant Pseudomonas aeruginosa strains originated from remediated sites.
Kaszab E; Szoboszlay S; Dura G; Radó J; Kovács B; Kriszt B
Int J Occup Med Environ Health; 2016; 29(3):503-16. PubMed ID: 26988888
[TBL] [Abstract][Full Text] [Related]
46. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
47. Virulence genes fliC, toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections.
Ertugrul BM; Oryasin E; Lipsky BA; Willke A; Bozdogan B
Infect Dis (Lond); 2018 Apr; 50(4):273-279. PubMed ID: 29078729
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
Garey KW; Vo QP; Larocco MT; Gentry LO; Tam VH
J Chemother; 2008 Dec; 20(6):714-20. PubMed ID: 19129069
[TBL] [Abstract][Full Text] [Related]
49. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
50. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
Sánchez-Diener I; Zamorano L; Peña C; Ocampo-Sosa A; Cabot G; Gómez-Zorrilla S; Almirante B; Aguilar M; Granados A; Calbo E; Rodriguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Navas A; Oliver A
Clin Microbiol Infect; 2020 Mar; 26(3):351-357. PubMed ID: 31288102
[TBL] [Abstract][Full Text] [Related]
51. Characterization of clinical extensively drug resistant Pseudomonas aeruginosa from a Chinese teaching hospital.
Zou M; Wang H; Shui J; Li J; Hu Y; Dou Q; Yan Q; Liu WE
J Infect Dev Ctries; 2018 Oct; 12(10):835-841. PubMed ID: 32004151
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
53. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
[No Abstract] [Full Text] [Related]
54. Characterization of environmental Pseudomonas aeruginosa using multilocus sequence typing scheme.
Radó J; Kaszab E; Petrovics T; Pászti J; Kriszt B; Szoboszlay S
J Med Microbiol; 2017 Oct; 66(10):1457-1466. PubMed ID: 28923132
[TBL] [Abstract][Full Text] [Related]
55. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
[TBL] [Abstract][Full Text] [Related]
56. Similar virulence properties of infection and colonization associated Pseudomonas aeruginosa.
Aditi ; Shariff M; Chhabra SK; Rahman MU
J Med Microbiol; 2017 Oct; 66(10):1489-1498. PubMed ID: 28893354
[TBL] [Abstract][Full Text] [Related]
57. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
58. Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates.
Gholami S; Tabatabaei M; Sohrabi N
Microb Pathog; 2017 Aug; 109():94-98. PubMed ID: 28549926
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of different virulence factors and their association with antimicrobial resistance among Pseudomonas aeruginosa clinical isolates from Egypt.
Edward EA; El Shehawy MR; Abouelfetouh A; Aboulmagd E
BMC Microbiol; 2023 Jun; 23(1):161. PubMed ID: 37270502
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of atypical virulotype and genetically diverse background among Pseudomonas aeruginosa isolates from a referral hospital in the Brazilian Amazon.
Rodrigues YC; Furlaneto IP; Maciel AHP; Quaresma AJPG; de Matos ECO; Conceição ML; Vieira MCDS; Brabo GLDC; Sarges EDSNF; Lima LNGC; Lima KVB
PLoS One; 2020; 15(9):e0238741. PubMed ID: 32911510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
